idx184
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2008 (NCT00730431)
Timeline
Indications
Mechanism of action
- Genome polyproteinINHIBITOR
Genome polyprotein inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- idx184
- idx184
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01371604 | Phase 2 | Jul 1, 2011 | Merck |
| NCT01157104 | Phase 1 | Jun 1, 2010 | Merck |
| NCT01011166 | Phase 2 | Nov 1, 2009 | Merck |
| NCT00807001 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2008 | Merck |
| NCT00730431 | Phase 1 | Jul 1, 2008 | Merck |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck | For profit | 5 | 5 | 2 | 2008 |
1 organizations
Page 1 / 1